Treatment of advanced esthesioneuroblastoma with high-dose chemotherapy and autologous bone marrow transplantation. A case report
- 15 January 1985
Abstract
A 46-year-old woman presented with an advanced unresectable esthesioneuroblastoma which failed to respond to radiation therapy and one course of chemotherapy. She underwent treatment with high-dose chemotherapy (cyclophosphamide, doxorubicin, and vinblastine) followed by autologous bone marrow transplantation. The major toxicity from the regimen was severe oropharyngeal mucositis. A complete remission was achieved and the patient is free of disease and asymptomatic 3.5 years after treatment.This publication has 8 references indexed in Scilit:
- Response of esthesioneuroblastoma to chemotherapy report of five cases and review of the literatureCancer, 1984
- High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancerThe American Journal of Medicine, 1981
- Cardiotoxicity associated with high-dose cyclophosphamide therapyArchives of Internal Medicine, 1981
- EsthesioneuroblastomaCancer, 1979
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphomaBlood, 1978
- SUCCESSFUL ENGRAFTMENT OF CRYOPRESERVED AUTOLOGOUS BONE-MARROW IN PATIENTS WITH MALIGNANT-LYMPHOMA1978
- Olfactory Neuroblastoma: Management and PrognosisJAMA Otolaryngology–Head & Neck Surgery, 1975